首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1550062

心臟瓣膜修復·置換市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2031年

Heart Valve Repair and Replacement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: 2024年08月30日 | 出版商:

Persistence Market Research | 英文 308 Pages | 商品交期: 2-5個工作天內

價格

簡介目錄

Persistence Market Research最近發布了一份關於全球心臟瓣膜修復和置換市場的詳細研究報告。該報告提供了對市場結構的全面了解，並對關鍵市場動態進行了詳細評估，包括推動因素、趨勢、機會和挑戰。

主要觀察

心臟瓣膜修復與置換市場規模（2024 年）：85.0634 億美元
市場預測金額（2031 年）：16,968,010,000 美元
全球市場成長率（2024-2031 年複合年增長率）：10.4%

心臟瓣膜修復更換市場 - 報告範圍：

心臟瓣膜修復和置換市場專注於用於修復或置換受損心臟瓣膜並確保血液正常流經心臟的設備和技術。心臟病患病率上升、人口老化以及微創手術技術的進步推動了市場成長。這些因素促使全球對心臟瓣膜修復和置換手術的需求不斷增長。

推動市場成長的因素：

全球心臟瓣膜修復和置換市場受到幾個關鍵因素的推動，包括主動脈瓣狹窄和風濕性心臟病等心臟病盛行率的上升。這些疾病的盛行率不斷上升，特別是在老年人中，刺激了對心臟瓣膜修復和置換的需求。此外，醫療保健系統正在迅速發展，醫療保健提供者採用新技術，透過更好的治療、藥物和療法來改善患者護理。政府支持改善醫療保健、有利的報銷政策和靈活的保險索賠的措施也有助於市場成長。在心臟瓣膜開發中越來越多地使用數據驅動技術也是一個主要驅動力。製造商正在利用醫院數據並實施物聯網和人工智慧等先進技術來設計智慧、高品質的心臟瓣膜。這些技術的採用預計將透過提高心臟瓣膜修復和置換手術的精確度和有效性來推動未來幾年的市場成長。

市場阻礙因素：

儘管心臟瓣膜修復和置換市場具有巨大的成長潛力，但仍面臨一些挑戰。主要阻礙因素之一是心臟瓣膜置換術的相關風險。心臟瓣膜置換術是侵入性的，具有重大風險，包括過度出血、心律不整、中風、腎臟損傷和感染。儘管微創技術風險較低，但由於與傳統侵入性手術相比成本相對較高，一些患者可能會猶豫是否選擇手術。這些風險和成本可能會影響市場成長，特別是在獲得先進醫療服務的機會有限的地區。

市場機會：

由於醫療基礎設施的進步和微創手術的採用增加，心臟瓣膜修復和置換市場提供了巨大的成長機會。人們對心血管疾病的認識不斷提高以及先進治療方案的可用性預計將推動心臟瓣膜修復和置換的需求。此外，瓣膜設計的持續創新和數據驅動技術的整合預計將為市場參與者提供開發下一代心臟瓣膜的新機會，從而改善患者的治療效果並降低風險。

本報告解決的關鍵問題

推動全球心臟瓣膜修復和置換市場成長的關鍵因素有哪些？
哪些類型的心臟瓣膜和手術技術正在推動各種醫療機構的需求？
技術進步如何影響心臟瓣膜修復與置換市場的競爭格局？
誰是心臟瓣膜修復和置換市場的主要參與者？
全球心臟瓣膜修復與置換市場的新趨勢與未來前景如何？

簡介/主要調查結果
過去的市場規模(一百萬美元)的分析，各疾病適應症，2019年～2023年
現在及未來市場規模(一百萬美元)的分析與預測，各疾病適應症，2024年～2031年
- 主動脈瓣膜狹窄症
- 主動脈瓣膜逆流症
- 二尖瓣狹窄症
- 二尖瓣逆流症
市場魅力分析:各疾病適應症

第11章全球心臟瓣膜修復·替換市場分析，各終端用戶

簡介/主要調查結果
過去的市場規模(一百萬美元)的分析，各終端用戶，2019年～2023年
現在及未來市場規模(一百萬美元)的分析與預測，各終端用戶，2024年～2031年
- 醫院
- 門診病人手術中心
- 心導管檢驗室
市場魅力分析:各終端用戶

第12章全球心臟瓣膜修復·置換市場分析，各地區

簡介
過去的市場規模(一百萬美元)的分析，各地區，2019年～2023年
現在及未來市場規模(一百萬美元)分析與預測，各地區，2024年～2031年
- 北美
- 南美
- 歐洲
- 中東·非洲(MEA)
- 東亞
- 南亞
- 大洋洲
市場魅力分析:各地區

第13章北美的心臟瓣膜修復·置換市場分析

第14章南美的心臟瓣膜修復·置換市場分析

第15章歐洲的心臟瓣膜修復·置換市場分析

第16章南亞的心臟瓣膜修復·置換市場分析

第17章東亞的心臟瓣膜修復·置換市場分析

第18章大洋洲的心臟瓣膜修復·置換市場分析

第19章中東·非洲的心臟瓣膜修復·置換市場分析

第20章新興國家的心臟瓣膜修復·置換市場分析

簡介
- 市場金額比較起來分析:各主要國家
- 世界 Vs. 各國成長比較
中國心臟瓣膜修復·置換市場分析
- 簡介
- 市場金額比較起來分析:市場各分類
- 市場金額(一百萬美元)分析與預測:市場各分類
- 中國的心臟瓣膜修復·置換市場 - 競爭情形
日本的心臟瓣膜修復·置換市場分析
- 簡介
- 市場金額比較起來分析:市場各分類
- 市場金額(一百萬美元)分析與預測:市場各分類
- 日本的心臟瓣膜修復·置換市場 - 競爭情形
印度的心臟瓣膜修復·置換市場分析
- 簡介
- 市場金額比較起來分析:市場各分類
- 市場金額(一百萬美元)分析與預測:市場各分類
- 印度的心臟瓣膜修復·置換市場 - 競爭情形

第21章市場結構分析

市場分析:各企業等級(心臟瓣膜修復·置換)
市場集中
主要企業的市場佔有率分析
市場影響分析

第22章競爭分析

競爭儀表板
競爭的詳細資訊
- Medtronic
- Abbott
- Edwards Lifesciences Corporation
- Boston Scientific Corporation
- CryoLife, Inc.
- LivaNova PLC
- Colibri Heart Valve
- JenaValve Technology, Inc.
- Micro Interventional Devices, Inc.
- Braile Biomedica
- Arbor Surgical Technologies, Inc.
- Aortech International Plc

第23章所使用的前提條件與縮寫

第24章調查手法

簡介目錄

Product Code: PMRREP3192

Persistence Market Research has recently released a detailed report on the global heart valve repair and replacement market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, offering a thorough understanding of the market structure.

Key Insights:

Heart Valve Repair and Replacement Market Size (2024E): US$ 8506.34 Mn
Projected Market Value (2031F): US$ 16968.01 Mn
Global Market Growth Rate (CAGR 2024 to 2031): 10.4%

Heart Valve Repair & Replacement Market - Report Scope:

The heart valve repair and replacement market focuses on devices and technologies used to repair or replace damaged heart valves, ensuring the proper flow of blood through the heart. The market growth is driven by the rising prevalence of cardiac disorders, the aging population, and advancements in minimally invasive surgical techniques. These factors are contributing to the increasing demand for heart valve repair and replacement procedures globally.

Market Growth Drivers:

The global heart valve repair and replacement market is driven by several key factors, including the rising prevalence of cardiac disorders such as aortic stenosis and rheumatic heart disease. The growing incidence of these conditions, particularly among the elderly, is fueling the demand for heart valve repair and replacement. Additionally, the healthcare system is rapidly evolving, with institutions adopting new technologies and improving patient care through better treatments, medications, and therapies. Government initiatives supporting healthcare improvements, along with favorable reimbursement policies and flexible insurance claims, are also contributing to market growth. Another significant driver is the increased usage of data-driven technologies in developing heart valves. Manufacturers are leveraging hospital data and implementing advanced technologies such as IoT and artificial intelligence to design smart, high-quality heart valves. The adoption of these technologies is expected to drive market growth in the coming years by enhancing the precision and effectiveness of heart valve repair and replacement procedures.

Market Restraints:

Despite the strong growth potential, the heart valve repair and replacement market faces several challenges. One of the primary restraints is the risk associated with heart valve replacement procedures, which are invasive and carry significant risks such as excessive bleeding, arrhythmia, stroke, renal issues, and infections. Although minimally invasive techniques offer lower risks, the cost of these procedures is relatively high compared to traditional invasive surgery, which can deter some patients from opting for surgery. These risks and costs are likely to impact the market's growth, particularly in regions with limited access to advanced healthcare services.

Market Opportunities:

The heart valve repair and replacement market presents substantial growth opportunities driven by advancements in healthcare infrastructure and the increasing adoption of minimally invasive procedures. The growing awareness of cardiovascular diseases and the availability of advanced treatment options are expected to boost the demand for heart valve repair and replacement. Additionally, continuous innovations in valve design and the integration of data-driven technologies will create new opportunities for market players to develop next-generation heart valves that offer improved outcomes and reduced risks for patients.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the heart valve repair and replacement market globally?
Which types of heart valves and surgical techniques are leading the demand in various healthcare settings?
How are technological advancements influencing the competitive landscape of the heart valve repair and replacement market?
Who are the key players in the heart valve repair and replacement market, and what strategies are they employing to enhance their market presence?
What are the emerging trends and future prospects in the global heart valve repair and replacement market?

Competitive Intelligence and Business Strategy:

Leading players in the global heart valve repair and replacement market, including companies such as Edwards Lifesciences, Medtronic, and Abbott Laboratories, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce advanced heart valve technologies, such as transcatheter aortic valve replacement (TAVR) and minimally invasive mitral valve repair. Collaborations with hospitals and research institutions facilitate the adoption of these technologies and improve patient outcomes. Emphasis on data-driven innovation, cost-effective solutions, and expanding access to advanced surgical options drives growth and strengthens market positioning in the dynamic heart valve repair and replacement industry.

Key Companies Profiled:

Medtronic
Abbott
Edwards Lifesciences Corporation
Boston Scientific Corporation
CryoLife, Inc.
LivaNova PLC
Colibri Heart Valve
JenaValve Technology, Inc.
Micro Interventional Devices, Inc.
Braile Biomedica
Arbor Surgical Technologies, Inc.
Aortech International Plc

Heart Valve Repair Replacement Market Categorization

Heart Valve Repair Replacement Market by By Product

Heart Valve Repair
Heart Valve Replacement
Tissue Heart Valves
Transcatheter Aortic Valve Implantation (TAVI)

Heart Valve Repair Replacement Market By Indication

Aortic Stenosis
Aortic Regurgitation
Mitral Stenosis
Mitral Regurgitation

Heart Valve Repair Replacement Market By End User

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

Heart Valve Repair Replacement Market by Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

1. Executive Summary

1.1. Global Market Outlook
1.2. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
3.3. Regulatory Scenario

4. Key Success Factors

4.1. Reimbursement Scenario
4.2. Heart Valve Procedure Statistics, 2019

5. Global Heart Valve Repair and Replacement Market - Pricing Analysis

5.1. Country Pricing Analysis By Product Type
5.2. Pricing Break-up
- 5.2.1. Manufacturer Level Pricing
- 5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark

6. Global Economic Outlook

6.1. Gross Domestic Product by Region & Country, 2019-2023
6.2. Global Healthcare Market Outlook

7. Global Heart Valve Repair and Replacement Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

8.1. Macro-Economic Factors
- 8.1.1. Global GDP Growth Outlook
- 8.1.2. Healthcare Expenditure by Country
- 8.1.3. Regional Healthcare Market Outlook
8.2. Forecast Factors - Relevance & Impact
- 8.2.1. Development and commercialization of heart valve therapies
- 8.2.2. Increasing incidence of congenital heart defects
- 8.2.3. Rise in geriatric population with structural heart disorders
- 8.2.4. Varied stringency of regulatory procedures
- 8.2.5. High costs associated with heart valve repair and replacement procedures
8.3. Value Chain
8.4. Market Dynamics
- 8.4.1. Drivers
- 8.4.2. Restraints
- 8.4.3. Opportunity Analysis

9. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
- 9.3.1. Heart Valve Repair
  - 9.3.1.1. Mitral Valve Annuloplasty Rings
  - 9.3.1.2. Transcatheter Mitral Valve Repair (TMVR)
- 9.3.2. Heart Valve Replacement
  - 9.3.2.1. Mechanical Heart Valves
    - 9.3.2.1.1. Mechanical Sutured Aortic Valve Replacements
    - 9.3.2.1.2. Mechanical Sutured Mitral Valve Replacements
  - 9.3.2.2. Tissue Heart Valves
    - 9.3.2.2.1. Tissue Sutured Aortic Valve Replacements
    - 9.3.2.2.2. Tissue Sutured Mitral Valve Replacements
    - 9.3.2.2.3. Tissue Sutureless Aortic Valve Replacements
  - 9.3.2.3. Transcatheter Aortic Valve Implantation (TAVI)
9.4. Market Attractiveness Analysis By Product Type

10. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Disease Indication

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2024-2031
- 10.3.1. Aortic Stenosis
- 10.3.2. Aortic Regurgitation
- 10.3.3. Mitral Stenosis
- 10.3.4. Mitral Regurgitation
10.4. Market Attractiveness Analysis By Disease Indication

11. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by End User

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
- 11.3.1. Hospitals
- 11.3.2. Ambulatory Surgical Centers
- 11.3.3. Cardiac Catheterization Laboratories
11.4. Market Attractiveness Analysis By End User

12. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Region

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. Middle East and Africa (MEA)
- 12.3.5. East Asia
- 12.3.6. South Asia
- 12.3.7. Oceania
12.4. Market Attractiveness Analysis By Region

13. North America Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 13.4.1. By Country
  - 13.4.1.1. U.S.
  - 13.4.1.2. Canada
- 13.4.2. By Product Type
- 13.4.3. By Disease Indication
- 13.4.4. By End User
13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Product Type
- 13.5.3. By Disease Indication
- 13.5.4. By End User
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis

14. Latin America Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 14.4.1. By Country
  - 14.4.1.1. Brazil
  - 14.4.1.2. Mexico
  - 14.4.1.3. Rest of Latin America
- 14.4.2. By Product Type
- 14.4.3. By Disease Indication
- 14.4.4. By End User
14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Product Type
- 14.5.3. By Disease Indication
- 14.5.4. By End User
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis

15. Europe Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 15.4.1. By Country
  - 15.4.1.1. Germany
  - 15.4.1.2. Italy
  - 15.4.1.3. France
  - 15.4.1.4. U.K.
  - 15.4.1.5. Spain
  - 15.4.1.6. BENELUX
  - 15.4.1.7. Russia
  - 15.4.1.8. Rest of Europe
- 15.4.2. By Product Type
- 15.4.3. By Disease Indication
- 15.4.4. By End User
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Product Type
- 15.5.3. By Disease Indication
- 15.5.4. By End User
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis

16. South Asia Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 16.4.1. By Country
  - 16.4.1.1. India
  - 16.4.1.2. Thailand
  - 16.4.1.3. Indonesia
  - 16.4.1.4. Malaysia
  - 16.4.1.5. Rest of South Asia
- 16.4.2. By Product Type
- 16.4.3. By Disease Indication
- 16.4.4. By End User
16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Product Type
- 16.5.3. By Disease Indication
- 16.5.4. By End User
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis

17. East Asia Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 17.4.1. By Country
  - 17.4.1.1. China
  - 17.4.1.2. Japan
  - 17.4.1.3. South Korea
- 17.4.2. By Product Type
- 17.4.3. By Disease Indication
- 17.4.4. By End User
17.5. Market Attractiveness Analysis
- 17.5.1. By Country
- 17.5.2. By Product Type
- 17.5.3. By Disease Indication
- 17.5.4. By End User
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis

18. Oceania Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 18.4.1. By Country
  - 18.4.1.1. Australia
  - 18.4.1.2. New Zealand
- 18.4.2. By Product Type
- 18.4.3. By Disease Indication
- 18.4.4. By End User
18.5. Market Attractiveness Analysis
- 18.5.1. By Country
- 18.5.2. By Product Type
- 18.5.3. By Disease Indication
- 18.5.4. By End User
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 19.4.1. By Country
  - 19.4.1.1. GCC Countries
  - 19.4.1.2. Northern Africa
  - 19.4.1.3. South Africa
  - 19.4.1.4. Rest of Middle East and Africa
- 19.4.2. By Product Type
- 19.4.3. By Disease Indication
- 19.4.4. By End User
19.5. Market Attractiveness Analysis
- 19.5.1. By Country
- 19.5.2. By Product Type
- 19.5.3. By Disease Indication
- 19.5.4. By End User
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis

20. Emerging Countries Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

20.1. Introduction
- 20.1.1. Market Value Proportion Analysis, By Key Countries
- 20.1.2. Global Vs. Country Growth Comparison
20.2. China Heart Valve Repair and Replacement Market Analysis
- 20.2.1. Introduction
- 20.2.2. Market Value Proportion Analysis by Market Taxonomy
- 20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
  - 20.2.3.1. By Product Type
  - 20.2.3.2. By Disease Indication
  - 20.2.3.3. By End User
- 20.2.4. China Heart Valve Repair and Replacement Market - Competition Landscape
20.3. Japan Heart Valve Repair and Replacement Market Analysis
- 20.3.1. Introduction
- 20.3.2. Market Value Proportion Analysis by Market Taxonomy
- 20.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
  - 20.3.3.1. By Product Type
  - 20.3.3.2. By Disease Indication
  - 20.3.3.3. By End User
- 20.3.4. Japan Heart Valve Repair and Replacement Market - Competition Landscape
20.4. India Heart Valve Repair and Replacement Market Analysis
- 20.4.1. Introduction
- 20.4.2. Market Value Proportion Analysis by Market Taxonomy
- 20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
  - 20.4.3.1. By Product Type
  - 20.4.3.2. By Disease Indication
  - 20.4.3.3. By End User
- 20.4.4. India Heart Valve Repair and Replacement Market - Competition Landscape

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies (Heart Valve Repair and Replacement)
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
- 21.4.1. By Regional footprint of Players
- 21.4.2. Product foot print by Players
- 21.4.3. Channel Foot Print by Players

22. Competition Analysis

22.1. Competition Dashboard
22.2. Competition Deep Dive
- 22.2.1. Medtronic
  - 22.2.1.1. Overview
  - 22.2.1.2. Product Portfolio
  - 22.2.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.1.4. Sales Footprint
  - 22.2.1.5. Strategy Overview
    - 22.2.1.5.1. Marketing Strategy
    - 22.2.1.5.2. Product Strategy
    - 22.2.1.5.3. Channel Strategy
- 22.2.2. Abbott
  - 22.2.2.1. Overview
  - 22.2.2.2. Product Portfolio
  - 22.2.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.2.4. Sales Footprint
  - 22.2.2.5. Strategy Overview
    - 22.2.2.5.1. Marketing Strategy
    - 22.2.2.5.2. Product Strategy
    - 22.2.2.5.3. Channel Strategy
- 22.2.3. Edwards Lifesciences Corporation
  - 22.2.3.1. Overview
  - 22.2.3.2. Product Portfolio
  - 22.2.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.3.4. Sales Footprint
  - 22.2.3.5. Strategy Overview
    - 22.2.3.5.1. Marketing Strategy
    - 22.2.3.5.2. Product Strategy
    - 22.2.3.5.3. Channel Strategy
- 22.2.4. Boston Scientific Corporation
  - 22.2.4.1. Overview
  - 22.2.4.2. Product Portfolio
  - 22.2.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.4.4. Sales Footprint
  - 22.2.4.5. Strategy Overview
    - 22.2.4.5.1. Marketing Strategy
    - 22.2.4.5.2. Product Strategy
    - 22.2.4.5.3. Channel Strategy
- 22.2.5. CryoLife, Inc.
  - 22.2.5.1. Overview
  - 22.2.5.2. Product Portfolio
  - 22.2.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.5.4. Sales Footprint
  - 22.2.5.5. Strategy Overview
    - 22.2.5.5.1. Marketing Strategy
    - 22.2.5.5.2. Product Strategy
    - 22.2.5.5.3. Channel Strategy
- 22.2.6. LivaNova PLC
  - 22.2.6.1. Overview
  - 22.2.6.2. Product Portfolio
  - 22.2.6.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.6.4. Sales Footprint
  - 22.2.6.5. Strategy Overview
    - 22.2.6.5.1. Marketing Strategy
    - 22.2.6.5.2. Product Strategy
    - 22.2.6.5.3. Channel Strategy
- 22.2.7. Colibri Heart Valve
  - 22.2.7.1. Overview
  - 22.2.7.2. Product Portfolio
  - 22.2.7.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.7.4. Sales Footprint
  - 22.2.7.5. Strategy Overview
    - 22.2.7.5.1. Marketing Strategy
    - 22.2.7.5.2. Product Strategy
    - 22.2.7.5.3. Channel Strategy
- 22.2.8. JenaValve Technology, Inc.
  - 22.2.8.1. Overview
  - 22.2.8.2. Product Portfolio
  - 22.2.8.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.8.4. Sales Footprint
  - 22.2.8.5. Strategy Overview
    - 22.2.8.5.1. Marketing Strategy
    - 22.2.8.5.2. Product Strategy
    - 22.2.8.5.3. Channel Strategy
- 22.2.9. Micro Interventional Devices, Inc.
  - 22.2.9.1. Overview
  - 22.2.9.2. Product Portfolio
  - 22.2.9.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.9.4. Sales Footprint
  - 22.2.9.5. Strategy Overview
    - 22.2.9.5.1. Marketing Strategy
    - 22.2.9.5.2. Product Strategy
    - 22.2.9.5.3. Channel Strategy
- 22.2.10. Braile Biomedica
  - 22.2.10.1. Overview
  - 22.2.10.2. Product Portfolio
  - 22.2.10.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.10.4. Sales Footprint
  - 22.2.10.5. Strategy Overview
    - 22.2.10.5.1. Marketing Strategy
    - 22.2.10.5.2. Product Strategy
    - 22.2.10.5.3. Channel Strategy
- 22.2.11. Arbor Surgical Technologies, Inc.
  - 22.2.11.1. Overview
  - 22.2.11.2. Product Portfolio
  - 22.2.11.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.11.4. Sales Footprint
  - 22.2.11.5. Strategy Overview
    - 22.2.11.5.1. Marketing Strategy
    - 22.2.11.5.2. Product Strategy
    - 22.2.11.5.3. Channel Strategy
- 22.2.12. Aortech International Plc
  - 22.2.12.1. Overview
  - 22.2.12.2. Product Portfolio
  - 22.2.12.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.2.12.4. Sales Footprint
  - 22.2.12.5. Strategy Overview
    - 22.2.12.5.1. Marketing Strategy
    - 22.2.12.5.2. Product Strategy
    - 22.2.12.5.3. Channel Strategy